Healthcare chief financial officers are shifting their strategic focus toward managing external disruptions, according to ...

By Rabbi Moshe Elefant, Chief Operating Officer of OU Kosher  Key takeaways: Food manufacturers must anticipate and plan for upcoming regulatory bans on synthetic additives and volatile global trade ...

Australia is evaluating the impact of potential US tariffs of 200% on pharmaceutical imports, Treasurer Jim Chalmers said, while reiterating that his nation’s subsidies for certain drugs are not up ...

Johnson & Johnson (J&J) has halved its expectations for costs this year related to new tariffs and raised its full-year sales ...

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...

In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...

Welcome to our live blog tracking the latest news and developments from China. Stay updated with real-time insights into the ...

Key Points Adjusted EPS reached $2.77 in Q2, topping estimates by $0.09, but fell year over year. Revenue rose 5.8% year over year to $23.7 billion, exceeding estimates by $889 million. Full-year 2025 ...

U.S. President Donald Trump has announced that China may soon implement the death penalty for those involved in fentanyl ...

Early trading on Wall Street was quietly mixed as markets shift their attention toward a deluge of corporate earnings reports ...

President Donald Trump says it is “highly unlikely” he will fire Federal Reserve Chairman Jerome Powell “unless he has to ...

Shares of Johnson & Johnson climbed 6.8% in morning trading, enough to pace the S&P 500 index's SPX gainers. They were also headed for their biggest one-day gain and best postearnings reaction since ...